Home
Browse
Search
Statistics
About
Usage
PMID: 21691255
Megaraj V, Zhao T, Paumi CM, Gerk PM, Kim RB, Vore M
Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2).
Pharmacogenet Genomics. 2011 Aug;21(8):506-15.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
2
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:2:117
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:2:102
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:2:109
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:2:128
status:
NEW
view ABCC2 p.Thr1477Met details
Objectives To characterize the transport function of human wild-type (WT) MRP2 and four SNP variants,
S789F
,
A1450T
,
V417I
, and
T1477M
.
Login to comment
6
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:6:77
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:6:124
status:
NEW
view ABCC2 p.Ala1450Thr details
Results The Vmax for transport activity was decreased for all substrates for
S789F
, and for all substrates except E217G for
A1450T
.
Login to comment
7
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:7:0
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:7:125
status:
NEW
view ABCC2 p.Thr1477Met details
V417I
showed decreased apparent affinity for LTC4, E23G, and E217G, whereas transport was similar between wild-type (WT) and
T1477M
, except for a modest increase in TUDC transport.
Login to comment
8
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:8:70
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:8:80
status:
NEW
view ABCC2 p.Ala1450Thr details
Examination of substrate-stimulated MRP2-dependent ATPase activity of
S789F
and
A1450T
, SNPs located in MRP2 nucleotide-binding domains (NBDs), demonstrated significantly decreased ATPase activity and only modestly decreased affinity for ATP compared with WT.
Login to comment
9
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:9:29
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:9:61
status:
NEW
view ABCC2 p.Ala1450Thr details
Conclusion SNPs in the NBDs (
S789F
in the D-loop of NBD1, or
A1450T
near the ABC signature motif of NBD2) variably decreased the transport of all substrates.
Login to comment
10
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:10:0
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:10:151
status:
NEW
view ABCC2 p.Thr1477Met details
V417I
in membrane spanning domain 1 selectively decreased the apparent affinity for the glutathione and glucuronide conjugated substrates, whereas the
T1477M
SNP in the carboxyl terminus altered only TUDC transport.
Login to comment
48
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:48:195
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:48:180
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:48:187
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:48:206
status:
NEW
view ABCC2 p.Thr1477Met details
Construction of recombinant baculovirus containing multidrug resistance protein 2 The plasmid (pEF6/V5-His-TOPO; Invitrogen) containing the WT MRP2 (NM_000392) or its SNP variants
S789F
,
A1450T
,
V417I
, and
T1477M
, was used to create the MRP2 baculovirus expression vector.
Login to comment
49
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:49:644
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:49:510
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:49:559
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:49:769
status:
NEW
view ABCC2 p.Thr1477Met details
The pENTR 4 vector (Invitrogen) was mutated to generate a Hind III site using Quik Change II site-directed mutagenesis Kit (Stratagene; La Jolla, California, USA) using primers Hind IIIF and Hind IIIR (Hind IIIF: AGGCTCCAC- CATGGGAAGCTTCAGTCGACTGGATC; Hind IIIR: Table 1 Nucleotide sequence of variants in MRP2 leading to amino acid changes in multidrug resistance-associated protein 2 and their allelic frequencya SNP position Amino acid change Exon Location Allelic frequency Functional consequencesb C2366T
S789F
18 NBD1 (D loop) 0.01 (Japanese) 52 G4348A
A1450T
31 NBD2 (immediately after the ABC signature motif) 0.01 (Japanese) 52 G1249A
V417I
10 MSD1 (between transmembrane helices 7 and 8) 0.125/0.312/0.184 (Japanese/Iranian/Moroccan) 27,46,47,52,58,59 C4430T
T1477M
31 Carboxy terminal 0.006 (Japanese) MSD, membrane-spanning domain; NBD, nucleotide-binding domain; SNP, single nucleotide polymorphism.
Login to comment
56
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:56:46
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:56:31
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:56:38
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:56:57
status:
NEW
view ABCC2 p.Thr1477Met details
The pENTR4M containing the WT,
S789F
,
A1450T
,
V417I
, and
T1477M
SNPs were sequenced (MWG Biotech, Inc., Huntsville, Alabama, USA).
Login to comment
86
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:86:52
status:
NEW
view ABCC2 p.Ser789Phe details
Membrane ATPase measurements ATPase activity of WT,
S789F
, and A1450Twas measured as the level of sodium vanadate-sensitive release of inorganic phosphate from ATP [27].
Login to comment
94
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:94:19
status:
NEW
view ABCC2 p.Ser789Phe details
Although the SNPs,
S789F
and A1405T, are reported to have low allelic frequencies, they were of interest for inclusion in this study due to their predicted functional relevance when analyzed using the Polyphen Database [5], likely due to their location in the catalytic NBD domains of MRP2.
Login to comment
95
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:95:0
status:
NEW
view ABCC2 p.Val417Ile details
V417I
located in MSD1 is reported to have a much higher allelic frequency in several different populations and is frequently associated with adverse drug reactions in humans [27,28].
Login to comment
96
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:96:43
status:
NEW
view ABCC2 p.Thr1477Met details
There are no reports on the effects of SNP
T1477M
in the carboxy terminal on MRP2 function or expression; despite its low allelic frequency, the location of this SNP was of interest because the function of this portion of MRP2 is rarely studied [29].
Login to comment
97
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:97:175
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:97:160
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:97:167
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:97:186
status:
NEW
view ABCC2 p.Thr1477Met details
Protein expression of wild-type multidrug resistance-associated protein 2 and single nucleotide polymorphism variants in Sf9 cells WT MRP2 and the SNP variants
S789F
,
A1450T
,
V417I
, and
T1477M
were expressed in Sf9 cells using recombinant baculovirus.
Login to comment
101
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:101:123
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:101:133
status:
NEW
view ABCC2 p.Thr1477Met details
Statistical analysis of triplicate experiments showed that MRP2 expression was significantly reduced approximately 40% for
S789F
and
T1477M
variants, located in NBD1 and carboxy terminal region, respectively.
Login to comment
102
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:102:66
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:102:86
status:
NEW
view ABCC2 p.Ala1450Thr details
However, there was no significant difference in the expression of
V417I
in MSD1 or of
A1450T
in NBD2 compared with WT MRP2 (Fig. 1b).
Login to comment
108
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:108:234
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:108:221
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:108:227
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:108:175
status:
NEW
view ABCC2 p.Thr1477Met details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:108:240
status:
NEW
view ABCC2 p.Thr1477Met details
LTC4 and E23G were transported with classic Michaelis-Menten kinetics by WT MRP2; however, E217G and TUDC demonstrated positive Fig. 1 8000 6000 4000 Density(%)INT/mm2 2000 0
T1477M
* V417IA1450TS789F * WTEV 185 KD EV WT
S789F
A1450T
V417I
T1477M
(a) (b) Expression of WT multidrug resistance-associated protein 2 (MRP2) and its variants in Sf9 plasma membranes.
Login to comment
119
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:119:4
status:
NEW
view ABCC2 p.Ser789Phe details
The
S789F
variant located in the D-loop of NBD1 showed markedly reduced transport capacity of all substrates tested compared with WT; Vmax values were decreased by 40-60% relative to WT MRP2 (Fig. 2a-d; Table 2).
Login to comment
120
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:120:153
status:
NEW
view ABCC2 p.Ser789Phe details
The apparent affinity for substrates LTC4, E217G, and TUDC were unchanged, however, the Km for E23G was increased two-fold compared with WT MRP2 for the
S789F
SNP (Fig. 2b; Table 2).
Login to comment
121
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:121:4
status:
NEW
view ABCC2 p.Ala1450Thr details
The
A1450T
variant, which is located immediately after the ABC signature motif of NBD2, showed a 30-55% decrease in the Vmax for transport of LTC4, E23G, and TUDC, but not for E217G, whereas the apparent affinity for all of the substrates tested was not different from that of WT MRP2 (Fig. 2a-d; Table 2).
Login to comment
122
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:122:4
status:
NEW
view ABCC2 p.Val417Ile details
The
V417I
SNP, located in MSD1 between the seventh and eighth transmembrane helices, showed a 2-3-fold increased Km for LTC4 and E217G.
Login to comment
124
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:124:19
status:
NEW
view ABCC2 p.Val417Ile details
Interestingly, the
V417I
SNP also abolished the positive cooperativity in E217G transport, decreasing the HC from 2.2 to 1.1.
Login to comment
125
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:125:4
status:
NEW
view ABCC2 p.Thr1477Met details
The
T1477M
SNP located in the carboxyl terminal region induced modest but significant changes, and showed both increased Km (50%) and Vmax (13%) for TUDC, but a decrease in the Vmax for E23G (20%), whereas it did not influence the transport of other substrates (Fig. 2a-d; Table 2).
Login to comment
126
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:126:203
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:126:213
status:
NEW
view ABCC2 p.Ala1450Thr details
Substrate-stimulated ATPase activity of multidrug resistance-associated protein 2 and single nucleotide polymorphism variants To identify the mechanism of reduced transport activity of the SNP variants,
S789F
and
A1450T
, located in the ATP-binding domains, we determined their vanadate-sensitive ATPase activity in the presence of E217G (300 mmol/l).
Login to comment
127
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:127:562
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:127:556
status:
NEW
view ABCC2 p.Ser789Phe details
Isolated plasma membrane preparations of Sf9 cells expressing WT MRP2 showed a high capacity, drug-stimulated ATPase activity (Fig. 3a), as reported Fig. 2 2000 (a) (b) (c) (d) 1000 ATP-dependent3 H-LTC4 transport(pmol/min/mg) 0 0 5 10 LTC4 (μmol/l) 15 20 4000 1000 2000 3000 ATP-dependent3 H-E217G transport(pmol/min/mg) 0 0 100 200 E217G (μmol/l) 300 200 400 600 ATP-dependent3H-TUDC transport(pmol/min/mg) 0 0 100 200 TUDC (μmol/l) 300 2000 1000 ATP-dependent3 H-E23G transport(pmol/min/mg) 0 0 250 500 E23G (μmol/l) 750 1000 WT
S789F
V417I
T1477MA1450T ATP-dependent transport of wild-type (WT) and multidrug resistance-associated protein 2 single nucleotide polymorphism variants in Sf9 plasma membrane vesicles.
Login to comment
131
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:131:0
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:131:124
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:131:10
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:131:134
status:
NEW
view ABCC2 p.Ala1450Thr details
S789F
and
A1450T
exhibited vanadate-sensitive ATPase activity that was stimulated by E217G, however, the ATPase activity of
S789F
and
A1450T
was significantly decreased by 37 and 20%, respectively, compared with WT MRP2 (Fig. 3a).
Login to comment
132
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:132:138
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:132:148
status:
NEW
view ABCC2 p.Ala1450Thr details
To determine whether the maximal rates of ATP hydrolysis or affinity for the nucleotide were altered by the mutation seen in SNP variants
S789F
and
A1450T
, we compared their Km for ATP with that of WT MRP2 (Fig. 3b; Table 3).
Login to comment
133
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:133:213
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:133:236
status:
NEW
view ABCC2 p.Ala1450Thr details
Vesicular transport studies over a wide range of concentrations of ATP and a fixed E217G concentration (300 mmol/l) showed that the apparent Km values for ATP were increased modestly but not significantly in both
S789F
(125 mmol/l) and
A1450T
(101 mmol/l), compared with WT MRP2 (79 mmol/l) (Fig. 3b; Table 3).
Login to comment
134
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:134:74
status:
NEW
view ABCC2 p.Ala1450Thr details
The Vmax values were significantly decreased to 68% in S789Fand to 85% in
A1450T
(Table 3), consistent with the decreased E217G Vmax values seen in the saturation kinetics study (Table 2).
Login to comment
136
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:136:123
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:136:75
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:136:93
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:136:164
status:
NEW
view ABCC2 p.Thr1477Met details
Four SNPs were selected for characterization, one in each of the two NBDs (
S789F
in NBD1 and
A1450T
in NBD2), one in MSD1 (
V417I
), and one in the carboxy terminal (
T1477M
), to probe how changes in these portions of MRP2 protein might impact its transport properties.
Login to comment
138
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:138:17
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:138:133
status:
NEW
view ABCC2 p.Ala1450Thr details
The MRP2 variant
S789F
, located in the D-loop of NBD1, consistently decreased the Vmax for transport of all four substrates, whereas
A1450T
, located immediately after the ABC signature motif in NBD2, decreased the Vmax for all substrates except E217G.
Login to comment
145
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:145:34
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:145:74
status:
NEW
view ABCC2 p.Ala1450Thr details
We, therefore, questioned whether
S789F
, most likely located in NBS2, and
A1450T
, likely located in NBS1, might have differential effects on ATP binding and hydrolysis.
Login to comment
146
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:146:52
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:146:134
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:146:62
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:146:151
status:
NEW
view ABCC2 p.Ala1450Thr details
ATPase activity was significantly inhibited in both
S789F
and
A1450T
(Fig. 3a); whereas inhibition of ATPase activity was greater for
S789F
(37%) than
A1450T
(20%), the data did not permit unequivocal determination of the differential roles of NBS1 and NBS2 in ATP hydrolysis.
Login to comment
148
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:148:87
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:148:97
status:
NEW
view ABCC2 p.Ala1450Thr details
These data imply that irrespective of their locations in NBS1 or NBS2, neither variant
S789F
nor
A1450T
is directly involved in ATP binding, but rather both variants impact transport by decreasing ATP hydrolysis.
Login to comment
149
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:149:4
status:
NEW
view ABCC2 p.Val417Ile details
The
V417I
SNP, located in MSD1, was found to have decreased apparent affinity for LTC4, E23G, and E217G, but not for TUDC.
Login to comment
150
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:150:300
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:150:287
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:150:293
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:150:306
status:
NEW
view ABCC2 p.Thr1477Met details
These data imply that valine 417 plays a critical and selective role in binding of glutathione Table 2 Kinetic parameters for transport of substrates by wild-type multidrug resistance-associated protein 2 and four single nucleotide polymorphism variants Substrates Kinetic parameters WT
S789F
A1450T
V417I
T1477M
LTC4 Km 4 (1.8-6.5) 3 (1.8-4.4) 3 (2-3.6) 9 (7.8-12.7)* 6 (3.5-9) Vmax 1464 (1314-1713) 732 (648-816)* 658 (618-699)* 1366 (1200-1531) 1659 (1373-1945) E23G Km 103 (73-133) 235 (173-296)* 106 (64-148) 212 (95-330) 172 (88-230) Vmax 1458 (1339-1578) 615 (558-671)* 855 (746-964)* 1794 (1454-2134) 1157 (975-1338)* E217bG Km 84 (64-104) 72 (67-76) 88 (75-100) 263 (241-285)* 94 (89-100) Vmax 3154 (2691-3617) 1799 (1732-1866)* 2665 (2422-2907) 2647 (2520-2773) 2646 (2555-2737) HC 2.2 (1.4-3) 2.4 (2.1-2.6) 2 (1.6-2.4) 1.1 (1.1-1.2)* 1.8 (1.7-1.9) TUDC Km 71 (65-78) 64 (71-96) 71 (57-86) 74 (70-79) 109 (103-116)* Vmax 595 (563-627) 359 (343-376)* 424 (376-472)* 577 (553-600) 671 (645-699)* HC 2 (1.7-2.3) 2.3 (1.9-2.6) 1.8 (1.3-2.3) 2.6 (2.3-2.8) 2.2 (2-2.4) The kinetic parameters [Km (mmol/l); Vmax (pmol/mg/min); HC] of ATP-dependent transport of LTC4, E23G, E217G, and TUDC were determined in Sf9 plasma membrane vesicles.
Login to comment
159
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:159:0
status:
NEW
view ABCC2 p.Val417Ile details
V417I
also significantly reduced the HC for E217G from 2.2 in WT MRP2 to 1.1 (Fig. 2c; Table 2).
Login to comment
162
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:162:107
status:
NEW
view ABCC2 p.Val417Ile details
Our data showing increased apparent Km values for three glucuronide or glutathione conjugate substrates by
V417I
could be of clinical relevance since this is a common SNP in the population, and has been detected at frequencies of more than 20% in Caucasians and somewhat less in Japanese subjects (Table 1) [16].
Login to comment
164
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:164:4
status:
NEW
view ABCC2 p.Val417Ile details
The
V417I
SNP was also suggested to play a role in altered pharmacokinetics of talinolol, resulting in its lowered oral bioavailability and increased clearance after intravenous administration [47].
Login to comment
165
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:165:51
status:
NEW
view ABCC2 p.Val417Ile details
However, in population studies of MRP2 haplotypes,
V417I
was not found to associate with cholestatic or toxic hepatitis [48], and there was no effect on MRP2 protein expression in liver [49] or on serum-conjugated bilirubin levels in individuals with this SNP [16].
Login to comment
166
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:166:19
status:
NEW
view ABCC2 p.Thr1477Met details
Interestingly, the
T1477M
SNP located in the carboxy terminal region caused a selective decrease in the apparent affinity for TUDC but had no effect on the transport properties of other substrates.
Login to comment
168
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:168:120
status:
NEW
view ABCC2 p.Thr1477Met details
Quantitative immunoblot analysis demonstrated a decreased expression of approximately 40% for two of the SNPs, S789Fand
T1477M
, relative to WT MRP2.
Login to comment
169
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:169:464
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:169:474
status:
NEW
view ABCC2 p.Ala1450Thr details
To ensure that the reduced expression was not antibody-dependent, we performed immunoblots using two antibodies, M2 Fig. 3 25(a) (b) 20 15 VanadatesensitiveATPaseactivity3 H-E217Gtransport(pmol/min/mg) 10 5 0 A1450TS789FWTEV 3000 2000 1000 0 7500500025000 ** ** * ATP (μmol/l) WT S789FA1450T (a) ATPase activity of Sf9 membranes expressing wild-type (WT) multidrug resistance-associated protein 2 (MRP2) and the single nucleotide polymorphism (SNP) variants
S789F
and
A1450T
.
Login to comment
174
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:174:66
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:174:76
status:
NEW
view ABCC2 p.Ala1450Thr details
Transport in the Sf9 membrane vesicles expressing WT, or variants
S789F
and
A1450T
was measured in the presence of various concentrations of ATP ranging from 50 mmol/l to 7 mmol/l at a fixed concentration of [3 H]E217G (300 mmol/l) for 2 min at 371C.
Login to comment
177
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:177:103
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:177:142
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:177:113
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:177:148
status:
NEW
view ABCC2 p.Ala1450Thr details
Table 3 Kinetic parameters for ATP in wild-type multidrug resistance-associated protein 2 and variants
S789F
and
A1450T
Kinetic parameters WT
S789F
A1450T
Km 79 (43-114) 125 (96-155) 101 (57-146) Vmax 2630 (2433-2927) 1796 (1721-1870)* 2242 (2071-2413)* Nonlinear regression results [Km, (mmol/l); Vmax (pmol/mg/min)] were obtained from data in Fig. 3b.
Login to comment
183
ABCC2 p.Arg768Trp
X
ABCC2 p.Arg768Trp 21691255:183:120
status:
NEW
view ABCC2 p.Arg768Trp details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:183:14
status:
NEW
view ABCC2 p.Ser789Phe details
Expression of
S789F
(located in NBD1) was decreased to 59% of that of WT MRP2; a nearby but different mutation in NBD1 (
R768W
) of MRP2 was shown to be localized in the cytoplasm with an endoplasmic reticulum-like distribution [50].
Login to comment
185
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:185:25
status:
NEW
view ABCC2 p.Thr1477Met details
Similarly, expression of
T1477M
, in which the SNP is located 68 amino acid residues from the C-terminal of MRP2, was decreased to 62% of WT MRP2.
Login to comment
188
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:188:34
status:
NEW
view ABCC2 p.Thr1477Met details
Although the amino acid change in
T1477M
could contribute to the localization signal, it is located in a good distance from the C-terminal, suggesting an alternative mechanism for its decreased expression.
Login to comment
189
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:189:57
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:189:67
status:
NEW
view ABCC2 p.Thr1477Met details
From our studies, the data suggest that individuals with
S789F
and
T1477M
polymorphisms may have a lower expression level of MRP2 protein in the apical membrane of cells, and consequently, a reduced ability to export substrates.
Login to comment
190
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:190:104
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:190:111
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:190:118
status:
NEW
view ABCC2 p.Ala1450Thr details
Hirouchi et al. [52] also characterized the expression and transport activity of several MRP2 variants (
V417I
,
S789F
,
A1450T
) using a Tet-off recombinant adenovirus system in LLC-PK1 cells.
Login to comment
191
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:191:124
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:191:243
status:
NEW
view ABCC2 p.Ser789Phe details
However, these researchers did not detect any change in transport of E217G, LTC4, or 2,4-dinitrophenyl-S-glutathione by SNP
V417I
after normalization for expression levels, and further found that transport of these substrates was increased by
S789F
.
Login to comment
193
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:193:116
status:
NEW
view ABCC2 p.Ser789Phe details
Further analysis of the kinetic parameters showed that the Vmax for transport of 2,4-dinitrophenyl-S-glutathione by
S789F
was 1.3-fold greater than that of WT MRP2.
Login to comment
194
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:194:84
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:194:94
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:194:173
status:
NEW
view ABCC2 p.Ala1450Thr details
Finally, these researchers also showed a marked reduction in the expression of both
S789F
and
A1450T
to 24 and 18% of WT MRP2, respectively, such that transport of E217G by
A1450T
was too low to be normalized by its expression level [52].
Login to comment
196
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:196:37
status:
NEW
view ABCC2 p.Ala1450Thr details
These discrepancies, particularly in
A1450T
expression, indicate that the results of in-vitro transporter expression should be extrapolated to in-vivo situations with caution.
Login to comment
199
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:199:0
status:
NEW
view ABCC2 p.Val417Ile details
ABCC2 p.Thr1477Met
X
ABCC2 p.Thr1477Met 21691255:199:104
status:
NEW
view ABCC2 p.Thr1477Met details
V417I
selectively inhibited the transport of glutathione and glucuronide-conjugated substrates, whereas
T1477M
only altered the transport of TUDC, a hydrophilic bile acid.
Login to comment
200
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:200:22
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:200:125
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:200:32
status:
NEW
view ABCC2 p.Ala1450Thr details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:200:167
status:
NEW
view ABCC2 p.Ala1450Thr details
Even though the SNPs,
S789F
and
A1450T
, exist with low allelic frequency, the decreased expression and transport function of
S789F
and decreased transport activity of
A1450T
shown here could impact drug disposition in polymorphic individuals.
Login to comment
201
ABCC2 p.Ser789Phe
X
ABCC2 p.Ser789Phe 21691255:201:105
status:
NEW
view ABCC2 p.Ser789Phe details
ABCC2 p.Ala1450Thr
X
ABCC2 p.Ala1450Thr 21691255:201:114
status:
NEW
view ABCC2 p.Ala1450Thr details
Most likely because of the relative rarity of these SNPs, there are no reports of an association between
S789F
or
A1450T
and altered pharmacokinetics of MRP2 substrates.
Login to comment
204
ABCC2 p.Val417Ile
X
ABCC2 p.Val417Ile 21691255:204:262
status:
NEW
view ABCC2 p.Val417Ile details
These data indicate that closer evaluation of the role of these MRP2 SNPs in haplotype analyses or genome-wide association studies of adverse drug reactions and/or disease is warranted, as is careful monitoring of patients with the relatively frequent MRP2 SNP,
V417I
.
Login to comment